The treatment combines a new drug, inavolisib, with two older breast cancer drugs, fulvestrant (Faslodex ®) and palbociclib (Ibrance ®) . Inavolisib, which targets PIK3CA mutations, appears to be a ...
My group focuses on understanding cell signaling pathways primarily linked with the ubiquitin and autophagy systems and frequently altered in diseases, including neurodegenerative disease. To this end ...
Treatment for breast cancer starts with a correct diagnosis. We’re here to help you take the first steps toward getting the best cancer care. You may be reading this because you’re thinking about ...